KRYS - Krystal Biotech, Inc.

QQQ $ 622.92 nm (nm)

DIA $ 473.56 nm (nm)

SPY $ 677.80 nm (nm)

TLT $ 88.93 nm (nm)

GLD $ 366.00 nm (nm)

Previous Close

$ 203.26

Open

$ 198.38

Bid

$ 184.00 x 50

Ask

$ 225.00 x 10

Day's Range

$ 194.92 - $ 204.18

52 Week Range

$ 122.80 - $ 212.98

Volume

680,833

Average Volume

Market Cap

5.89B

Beta (5Y Monthly)

$ 0.77

PE Ratio (TTM)

$ 29.63

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-03-2025	09-30-2025	10-Q
2	08-04-2025	06-30-2025	10-Q
3	05-06-2025	03-31-2025	10-Q
4	02-19-2025	12-31-2024	10-K
5	11-04-2024	09-30-2024	10-Q
6	08-05-2024	06-30-2024	10-Q
7	05-06-2024	03-31-2024	10-Q
8	02-26-2024	12-31-2023	10-K
9	11-06-2023	09-30-2023	10-Q
10	08-07-2023	06-30-2023	10-Q
11	05-08-2023	03-31-2023	10-Q
12	02-27-2023	12-31-2022	10-K
13	11-07-2022	09-30-2022	10-Q
14	08-08-2022	06-30-2022	10-Q
15	05-09-2022	03-31-2022	10-Q
16	02-28-2022	12-31-2021	10-K
17	11-08-2021	09-30-2021	10-Q
18	08-09-2021	06-30-2021	10-Q
19	05-10-2021	03-31-2021	10-Q
20	03-01-2021	12-31-2020	10-K
21	11-09-2020	09-30-2020	10-Q
22	08-10-2020	06-30-2020	10-Q
23	05-04-2020	03-31-2020	10-Q
24	03-10-2020	12-31-2019	10-K
25	11-04-2019	09-30-2019	10-Q
26	08-05-2019	06-30-2019	10-Q
27	05-07-2019	03-31-2019	10-Q
28	03-12-2019	12-31-2018	10-K
29	11-05-2018	09-30-2018	10-Q
30	08-06-2018	06-30-2018	10-Q
31	05-07-2018	03-31-2018	10-Q
32	03-12-2018	12-31-2017	10-K
33	11-13-2017	09-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Citigroup Maintains Neutral on Krystal Bio...
11/04/2025 18:02:19

Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech (NASDAQ:KRYS) with a Neutral and raises the price target from ...

Chardan Capital Maintains Buy on Krystal B...
11/04/2025 13:23:08

Chardan Capital analyst Geulah Livshits maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from ...

Krystal Biotech Q3 EPS $2.66 Beats $1.03 E...
11/03/2025 12:01:18

Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $2.66 per share which beat the analyst consensus estimate of $1.03...

Earnings Scheduled For November 3, 2025
11/03/2025 11:11:31

$1000 Invested In Krystal Biotech 5 Years ...
10/31/2025 22:15:38

Krystal Biotech Unit Launches VYJUVEK In J...
10/22/2025 13:14:53

Krystal Biotech, Inc. today reported that, effective as of October 22, 2025, its wholly owned subsidiary, Krystal Biotech Japan...

Expert Outlook: Krystal Biotech Through Th...
10/17/2025 12:02:56

B of A Securities Maintains Buy on Krystal...
10/17/2025 11:02:28

B of A Securities analyst Alec Stranahan maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from...

$100 Invested In Krystal Biotech 5 Years A...
10/16/2025 20:45:22

Krystal Biotech Says It Gets US FDA's Plat...
10/14/2025 12:09:09

PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS) announced today that...

What's Driving the Market Sentiment Around...
10/10/2025 13:00:47

6-stocks-goldman-sachs-says-are-poised-for-potential-acquisition-in-next-12-months--including-a-huge-200-winner

6 Stocks Goldman Sachs Says Are Poised For...
09/30/2025 13:11:43

Goldman Sachs has highlighted six stocks that have a high probability of being acquisition targets in the next year.

If You Invested $1000 In Krystal Biotech S...
09/25/2025 16:45:23

Krystal Biotech (NASDAQ: KRYS) has outperformed the market over the past 5 years by 16.54% on an annualized basis producing an ...

Here's How Much $100 Invested In Krystal B...
09/18/2025 23:45:20

HC Wainwright & Co. Reiterates Buy on Krys...
09/15/2025 18:31:48

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $240 pric...

fda-expands-krystal-biotech-vyjuveks-label-allowing-newborns-access-to-gene-therapy-for-blistering-skin

FDA Expands Krystal Biotech Vyjuvek's Labe...
09/15/2025 17:39:14

The FDA approved Krystal Biotech's Vyjuvek label update, expanding treatment to newborns and offering flexible wound care b...

Krystal Biotech Announces FDA Approval For...
09/15/2025 12:06:29

If You Invested $100 In This Stock 5 Years...
09/02/2025 16:30:18

A Glimpse Into The Expert Outlook On Kryst...
08/22/2025 19:00:46

HC Wainwright & Co. Reiterates Buy on Krys...
08/22/2025 10:39:28

HC Wainwright & Co. analyst Joseph Pantginis reiterates Krystal Biotech (NASDAQ:KRYS) with a Buy and maintains $240 pric...